Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$461M |
| 2 |
Deutsche Bank
DB
|
+$435M |
| 3 |
NVIDIA
NVDA
|
+$310M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$308M |
| 5 |
Sempra
SRE
|
+$298M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$791M |
| 2 |
Microsoft
MSFT
|
+$436M |
| 3 |
Zscaler
ZS
|
+$346M |
| 4 |
Bank of America
BAC
|
+$274M |
| 5 |
Broadcom
AVGO
|
+$268M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.04% |
| 2 | Financials | 13.18% |
| 3 | Healthcare | 10.51% |
| 4 | Communication Services | 9.68% |
| 5 | Consumer Discretionary | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Ocular Therapeutix
OCUL
$1.79B
| $2.23M | ﹤0.01% |
240,021
-18,204
| -7% | -$142K |
|
|
EHAB
1602
DELISTED
Enhabit
EHAB
| $2.23M | ﹤0.01% |
230,831
-7,004
| -3% | -$64.6K |
|
1603
InvenTrust Properties
IVT
$2.76B
| $2.22M | ﹤0.01% |
81,130
-9,513
| -10% | -$264K |
|
1604
Kymera Therapeutics
KYMR
$8.51B
| $2.22M | ﹤0.01% |
50,915
-3,092
| -6% | -$106K |
|
1605
Goodyear
GT
$2B
| $2.22M | ﹤0.01% |
213,991
-35,010
| -14% | -$371K |
|
|
COOP
1606
DELISTED
Mr. Cooper
COOP
| $2.22M | ﹤0.01% |
14,869
-133,030
| -90% | -$17.1M |
|
1607
ABM Industries
ABM
$2.81B
| $2.22M | ﹤0.01% |
46,981
-7,407
| -14% | -$358K |
|
1608
Kilroy Realty
KRC
$4.52B
| $2.22M | ﹤0.01% |
64,584
+3,852
| +6% | +$126K |
|
1609
WD-40
WDFC
$3.05B
| $2.21M | ﹤0.01% |
9,702
-7,454
| -43% | -$1.75M |
|
|
SWTX
1610
DELISTED
SpringWorks Therapeutics
SWTX
| $2.21M | ﹤0.01% |
47,010
-9,188
| -16% | -$409K |
|
1611
Weis Markets
WMK
$1.91B
| $2.2M | ﹤0.01% |
30,383
-796
| -3% | -$62.3K |
|
1612
Exelixis
EXEL
$13.3B
| $2.2M | ﹤0.01% |
49,933
-25,887
| -34% | -$1.03M |
|
1613
Graham Holdings Company
GHC
$5.1B
| $2.2M | ﹤0.01% |
2,323
-1,913
| -45% | -$1.8M |
|
1614
PDF Solutions
PDFS
$1.93B
| $2.2M | ﹤0.01% |
102,702
-4,555
| -4% | -$86.2K |
|
1615
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
| $2.19M | ﹤0.01% |
51,656
-5,772
| -10% | -$240K |
|
1616
Agilon Health
AGL
$1.53B
| $2.19M | ﹤0.01% |
38,015
-9,416
| -20% | -$755K |
|
1617
East-West Bancorp
EWBC
$17.9B
| $2.18M | ﹤0.01% |
21,604
+88
| +0.4% | +$7.8K |
|
1618
Merchants Bancorp
MBIN
$2.53B
| $2.17M | ﹤0.01% |
65,722
+24,127
| +58% | +$781K |
|
1619
Vanguard Information Technology ETF
VGT
$139B
| $2.17M | ﹤0.01% |
26,200
| – | – |
|
1620
Mercury Systems
MRCY
$5.83B
| $2.17M | ﹤0.01% |
40,304
-15,930
| -28% | -$776K |
|
1621
Simply Good Foods
SMPL
$901M
| $2.16M | ﹤0.01% |
68,397
-12,182
| -15% | -$424K |
|
|
EFOR
1622
Everforth Inc
EFOR
$1.17B
| $2.15M | ﹤0.01% |
43,106
-6,833
| -14% | -$373K |
|
1623
NVE Corp
NVEC
$562M
| $2.15M | ﹤0.01% |
29,218
-1,086
| -4% | -$71.8K |
|
1624
Medpace
MEDP
$16.1B
| $2.15M | ﹤0.01% |
6,848
-79
| -1% | -$23.7K |
|
|
KC
1625
Kingsoft Cloud Holdings
KC
$3.34B
| $2.15M | ﹤0.01% |
171,639
+2,279
| +1% | +$29.5K |
|
Similar funds
Deutsche Bank's Q2 2025 Portfolio in Review
As of Q2 2025, Deutsche Bank held 3,800 positions worth $272B, up 7.6% from $252B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Deutsche Bank's Q2 2025 filing shows 197 new, 1,017 increased, 1,982 reduced and 197 closed positions. Its largest new stake was Amrize Ltd: 4,354,301 shares worth $216M. The largest sale was UnitedHealth, an estimated $791M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- Deutsche Bank's largest Q2 2025 buy was Amrize Ltd: 4,354,301 shares worth $216M.
- Deutsche Bank added most to Apple in Q2 2025, an estimated $461M increase.
- Deutsche Bank's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $791M.
- Deutsche Bank fully exited Discover Financial Services in Q2 2025, selling an estimated $189M.
- Deutsche Bank's ten largest holdings make up 27% of its $272B portfolio in Q2 2025.
- Deutsche Bank opened 197 new positions and closed 197 in Q2 2025.
- Deutsche Bank's portfolio value rose 7.6% quarter-over-quarter to $272B.
Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.